The Rx Research Corner is a blog written by the Research Team at PCMA. This blog will take a closer look at complex data and new research findings. Topics cover the PBM and prescription drug space and range from pricing, to policies, and to patient issues such as access and equity.
Pharmacy Benefit Companies Partner to Support Rural Pharmacies and Patients
Pharmacy benefit companies negotiate rebates from drug companies, which they pass to health plan sponsors. Health plan sponsors then use the rebates to make pharmacy benefits more affordable for patients.
The Path of a Rebate: From Drug Companies, through Pharmacy Benefit Companies, to the Employer – and All the Way to Patients
Pharmacy benefit companies negotiate rebates from drug companies, which they pass to health plan sponsors. Health plan sponsors then use the rebates to make pharmacy benefits more affordable for patients.
In Their Pharmacy Benefit Company Relationships, Employers have Choice, Flexibility, and the Final Say
Employers hire pharmacy benefit companies to administer their pharmacy benefits. These relationships are characterized by choice, flexibility, and decision-making.
Dr. Lawton Robert Burns Sheds Light on the Role of PBMs
A University of Pennsylvania professor’s deep dive into pharmacy benefit companies concludes that they are intermediaries that control costs and improve health outcomes.
A World Without PBMs: A Lesson from Economics
PBMs play a crucial role in the health care world. Ever wonder what it would be like if they weren’t around?
Inclusion vs. Exclusion from the IRA Medicare Direct Negotiation Drug List: When “Small” Doesn’t Really Mean Small
A data-driven look at the Medicare Part B and Part D drugs that might qualify for the “small biotech” exemption from drug price negotiation in the Inflation Reduction Act.